Page 26 - எடுப்போசை சுவாச துன்பம் நோய்க்குறி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Will Lead Business Development Activities After 14 Years as Executive Director of Maryland Stem Cell Research Fund MIAMI, May 18, 2021 (GLOBE NEWSWIRE)   Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, today announced the hiring of Dan Gincel, Ph.D. as Senior Vice President, Strategic Collaborations & Scientific Affairs. Dr. Gincel brings over 20 years of leadership experience overseeing development and commercialization of regenerative medicines, including cell and gene therapies, as well as establishing public-private collaborations and corporate partnerships. Previously, he served as Vice President of University Partnerships and a member of the Executive Leadership Team at the Maryland Technology Development Corporation (TEDCO), where he oversaw programs to accelerate the commercialization of technologies from federal, state, and

United statesDan gincelBrendan payneUniversity partnershipsLongeveron incLeadership teamStrategic collaborations scientific affairsStern ir incBusiness development activitiesMaryland technology development corporationBen gurion universityLongeveron or companyMaryland stem cell research fundLongeveron announcesSenior vice presidentStrategic collaborations